These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10973971)

  • 1. Degradation of amylin by insulin-degrading enzyme.
    Bennett RG; Duckworth WC; Hamel FG
    J Biol Chem; 2000 Nov; 275(47):36621-5. PubMed ID: 10973971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An insulin-degrading enzyme inhibitor decreases amylin degradation, increases amylin-induced cytotoxicity, and increases amyloid formation in insulinoma cell cultures.
    Bennett RG; Hamel FG; Duckworth WC
    Diabetes; 2003 Sep; 52(9):2315-20. PubMed ID: 12941771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis for the recognition and cleavages of IGF-II, TGF-alpha, and amylin by human insulin-degrading enzyme.
    Guo Q; Manolopoulou M; Bian Y; Schilling AB; Tang WJ
    J Mol Biol; 2010 Jan; 395(2):430-43. PubMed ID: 19896952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism.
    Shen Y; Joachimiak A; Rosner MR; Tang WJ
    Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Insulin-Degrading Enzyme Does Not Increase Islet Amyloid Deposition in Vitro.
    Hogan MF; Meier DT; Zraika S; Templin AT; Mellati M; Hull RL; Leissring MA; Kahn SE
    Endocrinology; 2016 Sep; 157(9):3462-8. PubMed ID: 27404391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
    Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
    Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual Exosite-binding Inhibitors of Insulin-degrading Enzyme Challenge Its Role as the Primary Mediator of Insulin Clearance in Vivo.
    Durham TB; Toth JL; Klimkowski VJ; Cao JX; Siesky AM; Alexander-Chacko J; Wu GY; Dixon JT; McGee JE; Wang Y; Guo SY; Cavitt RN; Schindler J; Thibodeaux SJ; Calvert NA; Coghlan MJ; Sindelar DK; Christe M; Kiselyov VV; Michael MD; Sloop KW
    J Biol Chem; 2015 Aug; 290(33):20044-59. PubMed ID: 26085101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of copper(II) and zinc(II) in the degradation of human and murine IAPP by insulin-degrading enzyme.
    Bellia F; Grasso G
    J Mass Spectrom; 2014 Apr; 49(4):274-9. PubMed ID: 24719342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Insulin-Degrading Enzyme to Treat Type 2 Diabetes Mellitus.
    Tang WJ
    Trends Endocrinol Metab; 2016 Jan; 27(1):24-34. PubMed ID: 26651592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin inhibition of the proteasome is dependent on degradation of insulin by insulin-degrading enzyme.
    Bennett RG; Fawcett J; Kruer MC; Duckworth WC; Hamel FG
    J Endocrinol; 2003 Jun; 177(3):399-405. PubMed ID: 12773120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Redox regulation of insulin degradation by insulin-degrading enzyme.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    PLoS One; 2011 Mar; 6(3):e18138. PubMed ID: 21448434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of relaxin family peptides by insulin-degrading enzyme.
    Bennett RG; Heimann DG; Hamel FG
    Ann N Y Acad Sci; 2009 Apr; 1160():38-41. PubMed ID: 19416156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
    Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K
    J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-covalent interaction of ubiquitin with insulin-degrading enzyme.
    Saric T; Müller D; Seitz HJ; Pavelic K
    Mol Cell Endocrinol; 2003 Jun; 204(1-2):11-20. PubMed ID: 12850277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Geniposide protects pancreatic INS-1E β cells from hIAPP-induced cell damage: potential involvement of insulin degrading-enzyme.
    Zhang Y; Yin F; Liu J; Wang Y
    Cell Biol Int; 2015 Apr; 39(4):373-8. PubMed ID: 25319222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-degrading enzyme: structure-function relationship and its possible roles in health and disease.
    Fernández-Gamba A; Leal MC; Morelli L; Castaño EM
    Curr Pharm Des; 2009; 15(31):3644-55. PubMed ID: 19925417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?
    Liu Z; Zhu H; Fang GG; Walsh K; Mwamburi M; Wolozin B; Abdul-Hay SO; Ikezu T; Leissring MA; Qiu WQ
    J Alzheimers Dis; 2012; 29(2):329-40. PubMed ID: 22232014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypyridinethione Inhibitors of Human Insulin-Degrading Enzyme.
    Adamek RN; Suire CN; Stokes RW; Brizuela MK; Cohen SM; Leissring MA
    ChemMedChem; 2021 Jun; 16(11):1775-1787. PubMed ID: 33686743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.